DMK Pharmaceuticals Corporation
US ˙ OTCPK ˙ US00547W3079

Introduction

This page provides a comprehensive analysis of the known insider trading history of Ahmed Shayan Fazlur Rahman. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Ahmed Shayan Fazlur Rahman has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:ADMP / Adamis Pharmaceuticals Corp 10% Owner 1,635,312
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Ahmed Shayan Fazlur Rahman. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases DMKPQ / DMK Pharmaceuticals Corporation - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in DMKPQ / DMK Pharmaceuticals Corporation. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

DMKPQ / DMK Pharmaceuticals Corporation Insider Trades
Insider Sales DMKPQ / DMK Pharmaceuticals Corporation - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in DMKPQ / DMK Pharmaceuticals Corporation. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2015-02-13 ADMP Rahman Ahmed Shayan Fazlur 12,076 6.4090 173 448.6300 77,395 180 227.5 -38,265 -49.44
2015-02-12 ADMP Rahman Ahmed Shayan Fazlur 23,000 6.4010 329 448.0700 147,223
2015-02-11 ADMP Rahman Ahmed Shayan Fazlur 10,000 6.4000 143 448.0000 64,000
2015-02-10 ADMP Rahman Ahmed Shayan Fazlur 5,000 6.3890 71 447.2300 31,945
2015-02-03 ADMP Rahman Ahmed Shayan Fazlur 20,000 6.6690 286 466.8300 133,380
2015-01-30 ADMP Rahman Ahmed Shayan Fazlur 10,000 6.9170 143 484.1900 69,170
2014-06-09 ADMP Rahman Ahmed Shayan Fazlur 26,585 5.2425 380 366.9750 139,372
2013-08-14 ADMP Rahman Ahmed Shayan Fazlur 15 0.5800 0 40.6000 9
2013-08-13 ADMP Rahman Ahmed Shayan Fazlur 7,000 0.5700 100 39.9000 3,990
2013-08-07 ADMP Rahman Ahmed Shayan Fazlur 15,000 0.5555 214 38.8850 8,332
2013-08-06 ADMP Rahman Ahmed Shayan Fazlur 25,000 0.5600 357 39.2000 14,000
2013-08-02 ADMP Rahman Ahmed Shayan Fazlur 56,000 0.5713 800 39.9910 31,993
2013-08-01 ADMP Rahman Ahmed Shayan Fazlur 11,960 0.5692 171 39.8440 6,808
2013-07-30 ADMP Rahman Ahmed Shayan Fazlur 28 0.5600 0 39.2000 16
2013-07-29 ADMP Rahman Ahmed Shayan Fazlur 10,300 0.5600 147 39.2000 5,768
2013-07-26 ADMP Rahman Ahmed Shayan Fazlur 25,000 0.5600 357 39.2000 14,000
2013-07-25 ADMP Rahman Ahmed Shayan Fazlur 32,900 0.5600 470 39.2000 18,424
2013-07-24 ADMP Rahman Ahmed Shayan Fazlur 5,000 0.6000 71 42.0000 3,000
2013-07-24 ADMP Rahman Ahmed Shayan Fazlur 32,100 0.5600 459 39.2000 17,976
2013-07-23 ADMP Rahman Ahmed Shayan Fazlur 66,000 0.5600 943 39.2000 36,960
2013-07-23 ADMP Rahman Ahmed Shayan Fazlur 5,000 0.5800 71 40.6000 2,900
2013-07-23 ADMP Rahman Ahmed Shayan Fazlur 24,900 0.5900 356 41.3000 14,691
2013-07-22 ADMP Rahman Ahmed Shayan Fazlur 20,000 0.6006 286 42.0420 12,012
2013-07-22 ADMP Rahman Ahmed Shayan Fazlur 5,000 0.6000 71 42.0000 3,000
2013-07-22 ADMP Rahman Ahmed Shayan Fazlur 10,000 0.5601 143 39.2070 5,601
2013-07-22 ADMP Rahman Ahmed Shayan Fazlur 10,324 0.5600 147 39.2000 5,781
2013-03-01 ADMP Rahman Ahmed Shayan Fazlur 4,575 0.8000 65 56.0000 3,660
2013-02-28 ADMP Rahman Ahmed Shayan Fazlur 6,678 0.7960 95 55.7200 5,316
2013-02-27 ADMP Rahman Ahmed Shayan Fazlur 14,000 0.8100 200 56.7000 11,340

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

DMKPQ / DMK Pharmaceuticals Corporation Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Ahmed Shayan Fazlur Rahman as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2015-02-13 2015-02-13 4 ADMP Adamis Pharmaceuticals Corp
Common Stock, par value $0.0001
S - Sale -12,076 1,635,312 -0.73 6.41 -77,395 10,480,715
2015-02-12 2015-02-12 4 ADMP Adamis Pharmaceuticals Corp
Common Stock, par value $0.0001
S - Sale -23,000 1,647,388 -1.38 6.40 -147,223 10,544,931
2015-02-12 2015-02-11 4 ADMP Adamis Pharmaceuticals Corp
Common Stock, par value $0.0001
S - Sale -10,000 1,670,388 -0.60 6.40 -64,000 10,690,483
2015-02-12 2015-02-10 4 ADMP Adamis Pharmaceuticals Corp
Common Stock, par value $0.0001
S - Sale -5,000 1,680,388 -0.30 6.39 -31,945 10,735,999
2015-02-03 2015-02-03 4 ADMP Adamis Pharmaceuticals Corp
Common Stock, par value $0.0001
S - Sale -20,000 1,685,388 -1.17 6.67 -133,380 11,239,853
2015-02-03 2015-01-30 4 ADMP Adamis Pharmaceuticals Corp
Common Stock, par value $0.0001
S - Sale -10,000 1,705,388 -0.58 6.92 -69,170 11,796,169
2014-06-11 2014-06-09 4 ADMP Adamis Pharmaceuticals Corp
Common Stock, par value $0.0001
S - Sale -26,585 1,715,388 -1.53 5.24 -139,372 8,992,922
2013-08-15 2013-08-14 4 ADMP Adamis Pharmaceuticals Corp
Common Stock, par value $0.0001
S - Sale -15 29,613,540 0.00 0.58 -9 17,175,853
2013-08-15 2013-08-13 4 ADMP Adamis Pharmaceuticals Corp
Common Stock, par value $0.0001
S - Sale -7,000 29,613,555 -0.02 0.57 -3,990 16,879,726
2013-08-08 2013-08-07 4 ADMP Adamis Pharmaceuticals Corp
Common Stock, par value $0.0001
S - Sale -15,000 29,620,555 -0.05 0.56 -8,332 16,454,218
2013-08-08 2013-08-06 4 ADMP Adamis Pharmaceuticals Corp
Common Stock, par value $0.0001
S - Sale -25,000 29,635,555 -0.08 0.56 -14,000 16,595,911
2013-08-05 2013-08-02 4 ADMP Adamis Pharmaceuticals Corp
Common Stock, par value $0.0001
S - Sale -56,000 29,660,555 -0.19 0.57 -31,993 16,945,075
2013-08-05 2013-08-01 4 ADMP Adamis Pharmaceuticals Corp
Common Stock, par value $0.0001
S - Sale -11,960 29,716,555 -0.04 0.57 -6,808 16,914,663
2013-07-31 2013-07-30 4 ADMP Adamis Pharmaceuticals Corp
Common Stock, par value $0.0001
S - Sale -28 29,728,515 0.00 0.56 -16 16,647,968
2013-07-31 2013-07-29 4 ADMP Adamis Pharmaceuticals Corp
Common Stock, par value $0.0001
S - Sale -10,300 29,728,543 -0.03 0.56 -5,768 16,647,984
2013-07-26 2013-07-26 4 ADMP Adamis Pharmaceuticals Corp
Common Stock, par value $0.0001
S - Sale -25,000 29,738,843 -0.08 0.56 -14,000 16,653,752
2013-07-26 2013-07-25 4 ADMP Adamis Pharmaceuticals Corp
Common Stock, par value $0.0001
S - Sale -32,900 29,763,843 -0.11 0.56 -18,424 16,667,752
2013-07-26 2013-07-24 4 ADMP Adamis Pharmaceuticals Corp
Common Stock, par value $0.0001
S - Sale -32,100 29,796,743 -0.11 0.56 -17,976 16,686,176
2013-07-26 2013-07-24 4 ADMP Adamis Pharmaceuticals Corp
Common Stock, par value $0.0001
S - Sale -5,000 29,828,843 -0.02 0.60 -3,000 17,897,306
2013-07-24 2013-07-23 4 ADMP Adamis Pharmaceuticals Corp
Common Stock, par value $0.0001
S - Sale -24,900 29,833,843 -0.08 0.59 -14,691 17,601,967
2013-07-24 2013-07-23 4 ADMP Adamis Pharmaceuticals Corp
Common Stock, par value $0.0001
S - Sale -5,000 29,858,743 -0.02 0.58 -2,900 17,318,071
2013-07-24 2013-07-23 4 ADMP Adamis Pharmaceuticals Corp
Common Stock, par value $0.0001
S - Sale -66,000 29,863,743 -0.22 0.56 -36,960 16,723,696
2013-07-24 2013-07-22 4 ADMP Adamis Pharmaceuticals Corp
Common Stock, par value $0.0001
S - Sale -10,324 29,929,743 -0.03 0.56 -5,781 16,760,656
2013-07-24 2013-07-22 4 ADMP Adamis Pharmaceuticals Corp
Common Stock, par value $0.0001
S - Sale -10,000 29,940,067 -0.03 0.56 -5,601 16,769,432
2013-07-24 2013-07-22 4 ADMP Adamis Pharmaceuticals Corp
Common Stock, par value $0.0001
S - Sale -5,000 29,950,067 -0.02 0.60 -3,000 17,970,040
2013-07-24 2013-07-22 4 ADMP Adamis Pharmaceuticals Corp
Common Stock, par value $0.0001
S - Sale -20,000 29,955,067 -0.07 0.60 -12,012 17,991,013
2013-03-05 2013-03-01 4 ADMP Adamis Pharmaceuticals Corp
Common Stock, par value $0.0001
S - Sale -4,575 29,975,067 -0.02 0.80 -3,660 23,980,054
2013-03-01 2013-02-28 4 ADMP Adamis Pharmaceuticals Corp
Common Stock, par value $0.0001
S - Sale -6,678 29,979,642 -0.02 0.80 -5,316 23,863,795
2013-03-01 2013-02-27 4 ADMP Adamis Pharmaceuticals Corp
Common Stock, par value $0.0001
S - Sale -14,000 29,986,320 -0.05 0.81 -11,340 24,288,919
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)